Richard A Bernstein

  • 5916 Citations
1994 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Neurovascular Critical Care, Stroke, Stroke of unknown cause, stroke in young people, acute stroke therapy, atrial fibrillation, stem cell therapy for stroke.

Certifications and Licenses

Vascular Neurology
Neurology

Training Experience

1997Internship, Mount Sinai Hospital, Illinois
2000Residency, New York Presbyterian Hospital
2001Fellowship, Univ. of CA-San Francisco Med. Ctr.

Education/Academic qualification

MD, PhD, Cornell University Medical College

… → 1996

Research interests

  • Stroke

Fingerprint Dive into the research topics where Richard A Bernstein is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Research Output

Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups

Diener, H. C., Sacco, R. L., Easton, J. D., Granger, C. B., Bar, M., Bernstein, R. A., Brainin, M., Brueckmann, M., Cronin, L., Donnan, G., Gdovinová, Z., Grauer, C., Kleine, E., Kleinig, T. J., Lyrer, P., Martins, S., Meyerhoff, J., Milling, T., Pfeilschifter, W., Poli, S. & 4 others, Reif, M., Rose, D. Z., Šaňák, D. & Schäbitz, W. R., Jan 1 2020, (Accepted/In press) In : Stroke. p. 1758-1765 8 p.

Research output: Contribution to journalArticle

Open Access
  • Open Access
  • 1 Scopus citations

    Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis

    Farrant, M., Easton, J. D., Adelman, E. E., Cucchiara, B. L., Barsan, W. G., Tillman, H. J., Elm, J. J., Kim, A. S., Lindblad, A. S., Palesch, Y. Y., Zhao, W., Pauls, K., Walsh, K. B., Martí-Fàbregas, J., Bernstein, R. A. & Johnston, S. C., Sep 4 2019, In : JAMA network open. 2, 9, p. e1910769

    Research output: Contribution to journalArticle

    Open Access
  • Dabigatran for prevention of stroke after embolic stroke of undetermined source

    Diener, H. C., Sacco, R. L., Donald Easton, J., Granger, C. B., Bernstein, R. A., Uchiyama, S., Kreuzer, J., Cronin, L., Cotton, D., Grauer, C., Brueckmann, M., Chernyatina, M., Donnan, G., Ferro, J. M., Grond, M., Kallmünzer, B., Krupinski, J., Lee, B. C., Lemmens, R., Masjuan, J. & 5 others, Odinak, M., Saver, J. L., Schellinger, P. D., Toni, D. & Toyoda, K., May 16 2019, In : New England Journal of Medicine. 380, 20, p. 1906-1917 12 p.

    Research output: Contribution to journalArticle

  • 84 Scopus citations

    Evaluation of the effect of sodium–glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial

    on behalf of the EMPEROR-Reduced Trial Committees and Investigators, Executive Committee, National Coordinators, Consulting Statistician, Clinical Events Committee, Scientific Excellence Committee & Data Monitoring Committee, Oct 1 2019, In : European Journal of Heart Failure. 21, 10, p. 1270-1278 9 p.

    Research output: Contribution to journalArticle

    Open Access
  • 8 Scopus citations